首页> 外文期刊>Spectrochimica acta, Part A. Molecular and biomolecular spectroscopy >An efficient spectrofluorimetric method adopts doxazosin, terazosin and alfuzosin coupling with orthophthalaldehyde: Application in human plasma
【24h】

An efficient spectrofluorimetric method adopts doxazosin, terazosin and alfuzosin coupling with orthophthalaldehyde: Application in human plasma

机译:一种有效的光谱氟化物方法采用双唑嗪,唑嗪和苜蓿与邻苯二甲醛的偶氮剂:在人血浆中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

A new, selective and sensitive spectrofluorimetric method was designed for the quantitation of doxazosin (DOX), terazosin (TER) and alfuzosin (ALF) in their dosage forms and human plasma. The method adopts efficient derivatization of the studied drugs with ortho-phthalaldehyde (OPA), in the presence of 2-mercaptoethanol in borate buffer (pH 9.7) to generate a highly fluorescent isoindole derivatives, which can strongly enhance the fluorescence intensities of the studied drugs, allowing their sensitive determination at 430 nm after excitation at 337 nm. The fluorescence-concentration plots were rectilinear over the ranges (10.0-400.0) ng/mL. Detection and quantification limits were found to be (0.52-3.88) and (1.59-11.76) ng/mL, respectively. The proposed method was validated according to ICH guidelines, and successfully applied for the determination of pharmaceutical preparations of the studied drugs. Moreover, the high sensitivity of the proposed method permits its successful application to the analysis of the studied drugs in spiked human plasma with % recovery (96.12 +/- 134-100.66 +/- 0.57, n = 3). A proposal for the reaction mechanism was presented. (C) 2018 Elsevier B.V. All rights reserved.
机译:设计了一种新的选择和敏感的光谱氟化物方法,用于定量Doxazosin(DOX),Terazosin(TER)和血沸酶(ALF)的剂型和人血浆。该方法采用具有邻邻苯丙基(OPA)的研究药物的有效衍生化,在硼酸盐缓冲液(pH9.7)中存在2-巯基乙醇,产生高度荧光异吲哚衍生物,其能够强烈地增强所研究的药物的荧光强度,在337nm激发后,允许它们在430nm处敏感测定。荧光浓度图在范围内(10.0-400.0)Ng / ml。发现检测和定量限制分别为(0.52-3.88)和(1.59-11.76)Ng / ml。根据ICH指南验证所提出的方法,并成功地应用了研究的药物制剂的测定。此外,所提出的方法的高灵敏度允许其成功地应用于分析尖刺人血浆中研究的药物,%回收率(96.12 +/- 134-100.66 +/- 0.57,n = 3)。提出了一种反应机制的提案。 (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号